139 related articles for article (PubMed ID: 28800781)
1. Knowledge-guided gene prioritization reveals new insights into the mechanisms of chemoresistance.
Emad A; Cairns J; Kalari KR; Wang L; Sinha S
Genome Biol; 2017 Aug; 18(1):153. PubMed ID: 28800781
[TBL] [Abstract][Full Text] [Related]
2. A probabilistic knowledge graph for target identification.
Liu C; Xiao K; Yu C; Lei Y; Lyu K; Tian T; Zhao D; Zhou F; Tang H; Zeng J
PLoS Comput Biol; 2024 Apr; 20(4):e1011945. PubMed ID: 38578805
[TBL] [Abstract][Full Text] [Related]
3. Gene interaction enrichment and network analysis to identify dysregulated pathways and their interactions in complex diseases.
Liu Y; Koyutürk M; Barnholtz-Sloan JS; Chance MR
BMC Syst Biol; 2012 Jun; 6():65. PubMed ID: 22694839
[TBL] [Abstract][Full Text] [Related]
4. Network based integrated analysis of phenotype-genotype data for prioritization of candidate symptom genes.
Li X; Zhou X; Peng Y; Liu B; Zhang R; Hu J; Yu J; Jia C; Sun C
Biomed Res Int; 2014; 2014():435853. PubMed ID: 24991551
[TBL] [Abstract][Full Text] [Related]
5. Preclinical-to-clinical Anti-cancer Drug Response Prediction and Biomarker Identification Using TINDL.
Hostallero DE; Wei L; Wang L; Cairns J; Emad A
Genomics Proteomics Bioinformatics; 2023 Jun; 21(3):535-550. PubMed ID: 36775056
[TBL] [Abstract][Full Text] [Related]
6. A systematic study on drug-response associated genes using baseline gene expressions of the Cancer Cell Line Encyclopedia.
Liu X; Yang J; Zhang Y; Fang Y; Wang F; Wang J; Zheng X; Yang J
Sci Rep; 2016 Mar; 6():22811. PubMed ID: 26960563
[TBL] [Abstract][Full Text] [Related]
7. Amisulpride in the prevention of nausea and vomiting induced by cisplatin-based chemotherapy: a dose-escalation study.
Herrstedt J; Summers Y; Daugaard G; Christensen TB; Holmskov K; Taylor PD; Fox GM; Molassiotis A
Support Care Cancer; 2018 Jan; 26(1):139-145. PubMed ID: 28801850
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin-loaded environmentally friendly carbon dots as a novel drug delivery system for nucleus targeted cancer therapy.
Yuan Y; Guo B; Hao L; Liu N; Lin Y; Guo W; Li X; Gu B
Colloids Surf B Biointerfaces; 2017 Nov; 159():349-359. PubMed ID: 28806666
[TBL] [Abstract][Full Text] [Related]
9. Sirt3 attenuates doxorubicin-induced cardiac hypertrophy and mitochondrial dysfunction via suppression of Bnip3.
Du Q; Zhu B; Zhai Q; Yu B
Am J Transl Res; 2017; 9(7):3360-3373. PubMed ID: 28804553
[TBL] [Abstract][Full Text] [Related]
10. Synchronous colorectal liver metastases: focus on the elderly : An Effectiveness Study from Routine Care.
Albertsmeier M; Engel A; Guba MO; Stintzing S; Schiergens TS; Schubert-Fritschle G; Hölzel D; Werner J; Angele MK; Engel J
Langenbecks Arch Surg; 2017 Dec; 402(8):1223-1232. PubMed ID: 28803383
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and response to nedaplatin monotherapy in older patients with ovarian cancer.
Yoshida H; Shintani D; Ogasawara A; Fujiwara K
Arch Gynecol Obstet; 2017 Oct; 296(4):819-826. PubMed ID: 28803267
[TBL] [Abstract][Full Text] [Related]
12. The Safety and Efficacy of an Alcohol-Free Pancreatic Cyst Ablation Protocol.
Moyer MT; Sharzehi S; Mathew A; Levenick JM; Headlee BD; Blandford JT; Heisey HD; Birkholz JH; Ancrile BB; Maranki JL; Gusani NJ; McGarrity TJ; Dye CE
Gastroenterology; 2017 Nov; 153(5):1295-1303. PubMed ID: 28802565
[TBL] [Abstract][Full Text] [Related]
13. INST OX-05-024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trial.
Patt YZ; Murad W; Fekrazad MH; Baron AD; Bansal P; Boumber Y; Steinberg K; Lee SJ; Bedrick E; Du R; Lee FC
Cancer Med; 2017 Sep; 6(9):2042-2051. PubMed ID: 28801995
[TBL] [Abstract][Full Text] [Related]
14. Absence of cardiotoxicity with prolonged treatment and large accumulating doses of pegylated liposomal doxorubicin.
Blank N; Laskov I; Kessous R; Kogan L; Lau S; Sebag IA; Gotlieb WH; Rudski L
Cancer Chemother Pharmacol; 2017 Oct; 80(4):737-743. PubMed ID: 28801766
[TBL] [Abstract][Full Text] [Related]
15. Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer.
Syed SB; Arya H; Fu IH; Yeh TK; Periyasamy L; Hsieh HP; Coumar MS
Sci Rep; 2017 Aug; 7(1):7972. PubMed ID: 28801675
[TBL] [Abstract][Full Text] [Related]
16. Tissue-guided LASSO for prediction of clinical drug response using preclinical samples.
Huang EW; Bhope A; Lim J; Sinha S; Emad A
PLoS Comput Biol; 2020 Jan; 16(1):e1007607. PubMed ID: 31967990
[TBL] [Abstract][Full Text] [Related]
17. TheMarker: a comprehensive database of therapeutic biomarkers.
Zhang Y; Zhou Y; Zhou Y; Yu X; Shen X; Hong Y; Zhang Y; Wang S; Mou M; Zhang J; Tao L; Gao J; Qiu Y; Chen Y; Zhu F
Nucleic Acids Res; 2024 Jan; 52(D1):D1450-D1464. PubMed ID: 37850638
[TBL] [Abstract][Full Text] [Related]
18. The ELK3-DRP1 axis determines the chemosensitivity of triple-negative breast cancer cells to CDDP by regulating mitochondrial dynamics.
Park JD; Jang HJ; Choi SH; Jo GH; Choi JH; Hwang S; Park W; Park KS
Cell Death Discov; 2023 Jul; 9(1):237. PubMed ID: 37422450
[TBL] [Abstract][Full Text] [Related]
19. NeuPD-A Neural Network-Based Approach to Predict Antineoplastic Drug Response.
Shahzad M; Tahir MA; Alhussein M; Mobin A; Shams Malick RA; Anwar MS
Diagnostics (Basel); 2023 Jun; 13(12):. PubMed ID: 37370938
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
